Business

Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research

Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research.

articleCnbx Pharmaceuticals Inc.December 5, 20195/company/cannabics-pharmaceuticals-inc/news/cannabics-pharmaceuticals-announces-the-appointment-of-dr-yaakov-waksman-as-head-of-cannabidiol-research
Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research

About this update from Cnbx Pharmaceuticals Inc.

[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research\nDr. Waksman joined the company in November 2019\nPR Newswire\nTEL AVIV, Israel and BETHESDA, Maryland, Dec. 5, 2019\n\n\n\nTEL AVIV, Israel and BETHESDA, Maryland, Dec. 5, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that Dr. Yaakov Waksman is to join the company as Head of Cannabidiol Research.\n\n \n \n\n \nDr. Waksman, 66, is well known for his work under the supervision of Prof. Raphael Mechoulam at the Department of Natural Products, School of Pharmacy, Faculty of Medicine at The Hebrew University of Jerusalem. In his studies, Dr. Waksman has examined the effects of cannabinoids on the human immune system and  discovered that Cannabidiol can prevent the production of TNF - a discovery that had both theoretical and practical implications. Tumor necrosis factor (TNF) is a cell signaling protein [cytokine] involved in systemic inflammation and acute phase reactin. TNF is produced by activated macrophages and promotes inflammation. \nDr. Waksman holds a B.Sc. and a M.Sc earned at the Faculty of Agriculture in Rehovot, Israel. Mr. Waksman earned his PhD in Biology in 1995 at the Faculty of Agriculture at the Hebrew University of Jerusalem. \nDr. Waksman held post-doctoral positions under the supervision of Prof. Raphael Mechoulam, Prof. Esther Shoami and Prof. Ruth Galili at the Department of Natural Products, School of Pharmacy, Faculty of Medicine at The Hebrew University of Jerusalem, Ein-Karem (1994-1997), and at the Department of Microbiology & Immunology at the Medical College of Virginia, Virginia Commonwealth University [VCU] in Richmond, VA, USA (1996-9). \nDr. Waksman has also held teaching and research fellow positions at the Department of A...

More updates from Cnbx Pharmaceuticals Inc.